Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Moore

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|September 1, 1996
Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural elementW M Moore, R K Webber, K F Fok, et al.
European Journal of Pharmacology|January 24, 1995
Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthaseJ R Connor, P T Manning, S L Settle, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1995
Pneumococcal clearance function of the intact autotransplanted spleenB Zhao, W M Moore, L S Lamb, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2001
Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthaseA E Moormann, S Metz, M V Toth, et al.
European Journal of Pharmacology|March 16, 1993
Selective inhibition of the inducible nitric oxide synthase by aminoguanidineT P Misko, W M Moore, T P Kasten, et al.
Gastroenterology|March 1, 1995
Potential role of nitric oxide in a model of chronic colitis in rhesus macaquesK A Ribbons, X J Zhang, J H Thompson, et al.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
The American Journal of Physiology|February 1, 1994
Characterization of human uroguanylin: a member of the guanylin peptide familyT Kita, C E Smith, K F Fok, et al.
Journal of Medicinal Chemistry|February 2, 1996
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoformsW M Moore, R K Webber, K F Fok, et al.
Journal of Medicinal Chemistry|January 8, 1993
Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potencyS R Bertenshaw, R S Rogers, M K Stern, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|September 1, 1996
Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural elementW M Moore, R K Webber, K F Fok, et al.
European Journal of Pharmacology|January 24, 1995
Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthaseJ R Connor, P T Manning, S L Settle, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1995
Pneumococcal clearance function of the intact autotransplanted spleenB Zhao, W M Moore, L S Lamb, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2001
Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthaseA E Moormann, S Metz, M V Toth, et al.
European Journal of Pharmacology|March 16, 1993
Selective inhibition of the inducible nitric oxide synthase by aminoguanidineT P Misko, W M Moore, T P Kasten, et al.
Gastroenterology|March 1, 1995
Potential role of nitric oxide in a model of chronic colitis in rhesus macaquesK A Ribbons, X J Zhang, J H Thompson, et al.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
The American Journal of Physiology|February 1, 1994
Characterization of human uroguanylin: a member of the guanylin peptide familyT Kita, C E Smith, K F Fok, et al.
Journal of Medicinal Chemistry|February 2, 1996
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoformsW M Moore, R K Webber, K F Fok, et al.
Journal of Medicinal Chemistry|January 8, 1993
Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potencyS R Bertenshaw, R S Rogers, M K Stern, et al.
Pageof 9